EMGE | tickerfilter.com

Fundamental analysis

21%

Profitability 18%

Dept financing 18%

Liquidity 0%

Performance 30%

Performance

5 Days

0 0%

1 Month

14.29%

3 Months

0 0%

6 Months

-11.11%

1 Year

-11.11%

2 Year

-11.11%

Key data

Stock price

$0.00

P/E Ratio

N/A

DAY RANGE

$0.00 - $0.00

EPS

N/A

52 WEEK RANGE

$0.00 - $0.00

52 WEEK CHANGE

-$11.11

MARKET CAP

0.000

YIELD

N/A

SHARES OUTSTANDING

0.000

DIVIDEND

N/A

EX-DIVIDEND DATE

N/A

NEXT EARNINGS DATE

N/A

BETA

0.00

PUBLIC FLOAT

N/A

AVERAGE 10 VOLUME

$920,785

AVERAGE 30 VOLUME

$564,960

Company detail

CEO:
Region: US
Website: emergenthealthcorp.com
Employees: 6
IPO year: 2008

Issue type:
Market: OTCM
Industry: Wholesale/Wholesale – Drugs & Drug Proprietaries
Sector: Wholesale Trade

Emergent Health Corp. develops and sells regenerative medicine, neutraceuticals, and phytonutritionals. Vita-Stim is a nutrient that enhances the immune system, nourishes stem cells, and maintains health. Hungarest is a diet aid that controls appetite in the brain and stomach.

EMGE - Emergent Health Corp.